Forward Pharma Priced, Nasdaq: FWP
Developing an alternative to and challenging IP of Biogen Idec's Tecfidera for MS.
Industry: Health Care
First Day Return: -16.7%
FWP
Developing an alternative to and challenging IP of Biogen Idec's Tecfidera for MS.
| IPO Data | |
|---|---|
| IPO Date | 10/14/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $221 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Copenhagen, Denmark |
| Founded | 2005 |
| Employees at IPO | 10 |
| Website www.forward-pharma.com | |
IPO News for Forward Pharma
Forward Pharma (FWP) Performance
